Advertisement

The drug, known as muraglitazar, proposed for approval under the brand name Pargluva, was endorsed by a Food and Drug Administration panel last month.

But Cleveland Clinic researchers who analysed data the FDA made public before the panel vote found that patients taking Pargluva faced double the risk of death, heart attack or stroke, compared with those on dummy pills or a similar drug.

The study was published Thursday on the Journal of the American Medical Association Website. – (AP)

Visit our Diabetes Centre for more information.

October 2005
 

Print this article on

Rate this article Poor 1 2 3 4 5 Excellent

JOBS

Senior Secretary Gauteng - North/Sandton Infrastructure Resource Gauteng - Johannesburg Management Accountant R450,000-500,000 Per Annum Cost To Company Gauteng - Johannesburg Financial Manager R350,000-400,000 Per Annum Cost To Company Gauteng - Johannesburg Financial and Project Accountant R300,000-360,000 Per Annum Cost To Company Gauteng - Johannesburg Financial Accountant R380,000-420,000 Per Annum Cost To Company Gauteng - Johannesburg SSIS Business Intelligence Specialists (SSIS; SSAS) R350,000-500,000 Per Annum Cost To Company Gauteng - North/Sandton Financial Accountant R350,000-450,000 Per Annum Cost To Company Gauteng - South Find more jobs Register your CV Post a job